The introduction of new vaccines into developing countries. IV: Global Access Strategies

Richard T. Mahoney, Anatole Krattiger, John D. Clemens, Roy Curtiss

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


This paper offers a framework for managing a comprehensive Global Access Strategy for new vaccines in developing countries. It is aimed at strengthening the ability of public-sector entities to reach their goals. The Bill and Melinda Gates Foundation and The Rockefeller Foundation have been leaders in stimulating the creation of new organizations - public/private product development partnerships (PDPs) - that seek to accelerate vaccine development and distribution to meet the health needs of the world's poor. Case studies of two of these PDPs - the Salmonella Anti-pneumococcal Vaccine Program and the Pediatric Dengue Vaccine Initiative - examine development of such strategies. Relying on the application of innovation theory, the strategy leads to the identification of six Components of Innovation which cover all aspects of the vaccine innovation process. Appropriately modified, the proposed framework can be applied to the development and introduction of other products in developing countries including drugs, and nutritional and agricultural products.

Original languageEnglish (US)
Pages (from-to)4003-4011
Number of pages9
Issue number20
StatePublished - May 16 2007


  • Access
  • Developing country
  • Innovation
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'The introduction of new vaccines into developing countries. IV: Global Access Strategies'. Together they form a unique fingerprint.

Cite this